BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robinson J, Richardson M, Hickey J, James A, Pearce SH, Ball SG, Quinton R, Morris M, Miller M, Perros P. Patient knowledge of antithyroid drug-induced agranulocytosis. Eur Thyroid J 2014;3:245-51. [PMID: 25759801 DOI: 10.1159/000367990] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Nakamura H, Ide A, Kudo T, Nishihara E, Ito M, Miyauchi A. Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease. Eur Thyroid J 2016;5:253-60. [PMID: 28101490 DOI: 10.1159/000448586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
2 He Y, Li J, Zheng J, Khan Z, Qiang W, Gao F, Zhao Y, Shi B. Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center. J Endocrinol Invest 2017;40:733-40. [DOI: 10.1007/s40618-017-0626-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Zhu D, Zhang S, Cao X, Xia Q, Zhang Q, Deng D, Gao S, Yu H, Liu Y, Zhou H, Tao F, Sun X. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism. Endocr Pract 2021:S1530-891X(21)01113-7. [PMID: 34216800 DOI: 10.1016/j.eprac.2021.06.017] [Reference Citation Analysis]
4 Lawrence N, Cheetham T, Elder C. How do paediatricians use and monitor antithyroid drugs in the UK? A clinician survey. Clin Endocrinol (Oxf) 2019;91:417-23. [PMID: 31179554 DOI: 10.1111/cen.14046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Chen WT, Chi CC. Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: A systematic review and meta-analysis of pharmacogenomics studies. Br J Clin Pharmacol 2019;85:1878-87. [PMID: 31108563 DOI: 10.1111/bcp.13989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Vicente N, Cardoso L, Barros L, Carrilho F. Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management. Drugs R D 2017;17:91-6. [PMID: 28105610 DOI: 10.1007/s40268-017-0172-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
7 Bartalena L, Chiovato L, Vitti P. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any). J Endocrinol Invest 2016;39:1105-14. [PMID: 27319009 DOI: 10.1007/s40618-016-0505-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
8 Burch HB, Cooper DS. ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later. Eur J Endocrinol 2018;179:R261-74. [PMID: 30320502 DOI: 10.1530/EJE-18-0678] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
9 De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016;388:906-18. [PMID: 27038492 DOI: 10.1016/S0140-6736(16)00278-6] [Cited by in Crossref: 269] [Cited by in F6Publishing: 102] [Article Influence: 44.8] [Reference Citation Analysis]
10 Alarcon G, Figueredo V, Tarkoff J. Thyroid Disorders. Pediatr Rev 2021;42:604-18. [PMID: 34725220 DOI: 10.1542/pir.2020-001420] [Reference Citation Analysis]